These findings are in line with those from other studies conducted in China [7], Poland [6], Belarus, and Germany [8] further supporting the notion that high grade, hormone receptor-positive breast tumors of IDC histology may be predictors of the pathogenic RECQL variant status. The gene discussed is NR4A1; the disease is breast neoplasm.